Jewish Rehabilitation Hospital
Montreal, Quebec, H7V 1R2, Canada
NCT Number: NCT07039006
Stroke can severely limit a person's ability to move their arm, especially when trying to reach by extending the elbow. These challenges often persist long after the stroke and make everyday activities more difficult. The investigators are testing a feedback strategy called error augmentation (EA) feedback that intentionally exaggerates movement errors to promote motor learning.
In this study, the investigators designed a virtual reality training program that uses EA feedback to encourage people with chronic stroke to use more elbow extension during reaching. The EA feedback makes it appear as though the elbow is more bent than it actually is, prompting the participant to extend their elbow further than they normally would. By having the patient practice movement with enhanced feedback, the investigators predict that the patient will increase the range of motion and improve reaching ability.
This is a short, proof-of-concept study to evaluate whether EA feedback shows early promise for improving arm movement in people with upper limb motor impairment after stroke. Participants are randomly assigned to either an EA training group or a control group (no-EA feedback). Each person completes three 30-minute virtual reality training sessions over 1 week. The investigators assess arm movement and motor impairment before and after training, and again one hour after the training to determine if improvements are retained.
Findings from this preliminary study will help determine whether this EA-based training approach should be used in a longer 9-week clinical trial aimed at promoting long-term recovery of arm function after stroke.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Not applicable
Montreal, Quebec, H7V 1R2, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will undergo reaching training that includes a 30-degree elbow flexion error 3 times in 1 week.
Subjects will undergo reaching training that does not include EA feedback 3 times in 1 week.
Time frame: Prior to training.
The size of the active arm workspace area will be expressed as a ratio of the active workspace determined when the subject actively moves their arm through the horizontal workspace to the passive workspace that is defined by the examiner moving the arm through the same space.
Time frame: Baseline, immediately post-training, 1 hour post intervention.
Described as a measure of reaching precision accounting for accuracy and speed of reaching together with the amount of trunk compensation.
Time frame: Baseline, immediately post-training, 1 hour post intervention.
Elbow extension during a functional Test Task is calculated based on vectors between the markers placed on the acromion and the lateral epicondyle and between the lateral epicondyle and ulnar head of the affected arm. Arm movement onset/offset will be determined as the times at which the velocity of the endpoint marker increases/decreases and remains above/below 10% of the peak velocity.
Time frame: Baseline, immediately post-training, 1 hour post intervention.
The x,y root mean square distance between the endpoint marker and the target at the end of a reaching movement.
Time frame: Baseline, immediately post-training, 1 hour post intervention.
The time between the onset and offset of the movement.
Time frame: Baseline, immediately post-training, 1 hour post intervention.
The number of peaks on a tangential velocity trace of each reaching trial.
Time frame: Baseline, immediately post-training, 1 hour post intervention.
Described using the index of curvature where the ratio between the actual movement path and a straight line path between the initial and final targets.
McGill University
Other
Error Augmentation for Upper Limb Rehabilitation in Stroke Survivors: a Proof-of-concept Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02425345
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT05589402
Bone Diseases, Brain Diseases
Harlingen, Texas, United States
View Trial DetailsNCT06750692
Brain Diseases, Cardiovascular Diseases
Afyonkarahisar, Turkey (Türkiye)
View Trial DetailsNCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial Details